Author | Jennifer Temel, MD | OncLive

Author | Jennifer Temel, MD


Dr. Temel on Anorexia and Cachexia in NSCLC

July 13, 2015


Jennifer Temel, MD, Associate Professor, Medicine, Harvard Medical School Clinical Director, Thoracic Oncology, Massachusetts General Hospital, and Associate Director, Hematology/Oncology Fellowship Program, Dana-Farber, discusses a phase III study assessing the impact of anamorelin on body weight, lean body mass, and appetite in advanced non-small cell lung cancer (NSCLC) patients with anorexia and cachexia.